How does cumulative evidence from older adult-specific trials influence clinical practice? A difference-in-differences analysis in early-stage breast cancer

医学 阶段(地层学) 乳腺癌 癌症 肿瘤科 临床试验 妇科 内科学 生物 古生物学
作者
Woojung Lee,Anirban Basu,Josh J. Carlson,David L. Veenstra
出处
期刊:Contemporary Clinical Trials [Elsevier BV]
卷期号:128: 107135-107135
标识
DOI:10.1016/j.cct.2023.107135
摘要

Despite increasing focus on conducting cancer clinical trials in older adults, it is unclear whether such evidence influences practice patterns. We aimed to estimate the impact of cumulative evidence from older adult-specific trial results from the CALGB 9343 and PRIME II trials that found post-lumpectomy irradiation has little benefit among older adults with early-stage breast cancer (ESBC). Patients diagnosed with ESBC between 2000 and 2018 were identified from the SEER registry data. We examined the incremental immediate effect, incremental average yearly effect, and cumulative effect of a series of CALGB 9343 and PRIME II results on the utilization level of post-lumpectomy irradiation. We conducted difference-in-differences analyses, comparing those aged 70 or older vs. <65 years old. The initial 5-year CALGB 9343 results in 2004 led to a significant immediate (−0.038, 95% CI: −0.064, −0.012) and average yearly decrease (−0.008, 95% CI: −0.013, −0.003) in the probability of irradiation use among those aged 70 or older compared to those below 65 years of age. 11-year CALGB 9343 results in 2010 significantly accelerated the average yearly effect by 1.7 percentage points (95% CI: −0.030, −0.004). The other later results did not significantly change the time trend. The cumulative effect of all results between 2004 and 2018 was −26.3 percentage points (95% CI: −0.29, −0.24). Cumulative evidence from older adult-specific trials in ESBC led to decreasing use of irradiation over time among elderly patients. The rate of decrease after the initial results was accelerated by long-term follow-up results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
友好驳完成签到,获得积分10
4秒前
la完成签到,获得积分10
4秒前
4秒前
zhiwei完成签到 ,获得积分0
6秒前
初之发布了新的文献求助20
9秒前
猪猪hero发布了新的文献求助10
9秒前
10秒前
wuhuofeng完成签到,获得积分10
11秒前
11秒前
York Chang完成签到,获得积分10
11秒前
丫头发布了新的文献求助10
11秒前
11秒前
13秒前
王者归来发布了新的文献求助200
15秒前
伊星儿发布了新的文献求助10
15秒前
阿朱关注了科研通微信公众号
15秒前
16秒前
大模型应助zsy采纳,获得10
16秒前
初之完成签到,获得积分20
17秒前
猪猪hero发布了新的文献求助10
18秒前
mt13发布了新的文献求助10
20秒前
上官若男应助是江江哥啊采纳,获得10
21秒前
22秒前
22秒前
Rondab应助zhangtengteng采纳,获得10
23秒前
24秒前
小奋青完成签到 ,获得积分10
27秒前
moufei发布了新的文献求助10
28秒前
29秒前
迅速仰发布了新的文献求助10
29秒前
量子星尘发布了新的文献求助10
29秒前
29秒前
30秒前
yuyyyi发布了新的文献求助10
30秒前
31秒前
32秒前
孟梦完成签到 ,获得积分10
33秒前
bc应助专注的盼兰采纳,获得10
35秒前
35秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975426
求助须知:如何正确求助?哪些是违规求助? 3519848
关于积分的说明 11199831
捐赠科研通 3256122
什么是DOI,文献DOI怎么找? 1798124
邀请新用户注册赠送积分活动 877386
科研通“疑难数据库(出版商)”最低求助积分说明 806305